Incyte (INCY) EBITDA (2010 - 2026)

Incyte (INCY) has 17 years of EBITDA data on file, last reported at $697.9 million in Q2 2026.

• Quarterly EBITDA rose 31.6% year-over-year to $697.9 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $1.8 billion (up 50.32% YoY) and the FY2025 annual result came in at $1.5 billion, up 2368.56% from the prior year.
• EBITDA grew to $697.9 million in Q2 2026, from $301.1 million in the prior quarter.
• In the past five years, EBITDA ranged from a high of $697.9 million in Q2 2026 to a low of -$478.1 million in Q2 2024.
• A 5-year average of $209.7 million and a median of $199.5 million in 2023 frame the typical range for EBITDA.
• The widest YoY moves for EBITDA: up 271.01% in 2024, down 346.74% in 2024.
• Tracing INCY's EBITDA over 5 years: stood at $70.1 million in 2022, then surged by 167.17% to $187.3 million in 2023, then surged by 61.0% to $301.5 million in 2024, then advanced by 11.39% to $335.9 million in 2025, then surged by 107.79% to $697.9 million in 2026.
• The last three EBITDA figures came in at $697.9 million (Q2 2026), $301.1 million (Q1 2026), and $335.9 million (Q4 2025), per Business Quant data.